DJIA 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%

14.19 0.40 (2.89%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ACAD $14.19 2.89%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.80
Previous Close $13.79
Daily Range $13.50 - $14.36
52-Week Range $1.30 - $14.75
Market Cap $1.1B
P/E Ratio -40.56
Dividend (Yield) $0.00 (0.0%)
Volume 2,829,200
Average Daily Volume 4,111,309
Current FY EPS -$0.35

Sector

Healthcare

Industry

Drugs

ACADIA Pharmaceuticals, Inc. (ACAD) Description

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Website: http://www.acadia-pharm.com/

News & Commentary

Acadia: Multiple Data Points Suggest Further Upside In The Stock

Cramer's 'Mad Money' Recap: The Market and the Machines

Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE)

ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Comple

ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Comple

ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock

Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker B

Plus, there were purchases at Lionbridge Technologies and LivePerson.

Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker B

Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker Buys ACADIA

Mid-Morning Market Update: Markets Fall, Yahoo To Acquire Tumblr

Mid-Morning Market Update: Markets Fall, Yahoo To Acquire Tumblr

ACADIA Pharmaceuticals Added to NASDAQ Biotechnology Index

See More ACAD News...

ACAD's Top Competitors

ACAD $14.19 (2.89%)
Current stock: ACAD
AMGN $105.91 (0.27%)
Current stock: AMGN
GILD $55.81 (0.59%)
Current stock: GILD
BIIB $235.24 (1.13%)
Current stock: BIIB